Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.15) by 26.67 percent. This is a 8.33 percent increase over losses of $(0.12) per share from the same period last year.
Crude Oil Edges Higher; Caterpillar Earnings Top Views
U.S. stocks edged lower midway through trading, with the S&P 500 trading slightly lower on Tuesday.
The Dow traded down 0.11% to 32,892.75 while the NASDAQ fell 0.23% to 12,760.61. The S&P 500 also fell, dropping, 0.01% to 4,166.81.
